Abstract:LPS has been shown to elicit neuroinflammation associated with the up-regulation of the eicosanoid pathway in animal models; however, the regulatory mechanisms of TLR4 in brain neuroinflammatory conditions remain elusive. -Arrestins are key regulators of the GPCR signaling pathway and are involved in the leukotriene B4-induced leukocyte migration to initiate inflammatory response. However, the roles of -arrestins in eicosanoid regulation and related diseases are not clear. To address this issue, we conducted a study to investigate the effect of TLR4 on the eicosanoid pathway in ischemic stroke brain and to explore the underlying molecular regulation mechanism. Cerebral ischemia was produced by occlusion of the middle cerebral artery, followed by reperfusion for 24 h. We demonstrated that knockout of TLR4 improves ischemic stroke brain associated with eicosanoid down-regulation. Interestingly, genetic disruption of -arrestin-2 failed to decrease neuroinflammation in the damaged brain of TLR4(-/-) mice, which indicates the requirement of -arrestin-2 for TLR4 knockdown protection. Further study showed that the negative regulation of phosphorylated (phospho-)ERK1/2 and phospho-cytosolic phospholipase A(2) (cPLA(2)) by TLR4 deficiency was eliminated by genetic disruption of -arrestin-2. In addition, -arrestin-2 deficiency reversed the reduction of colocalization of phospho-ERK1/2 with phospho-cPLA(2) in TLR4(-/-) mice following ischemic stroke. Mechanistic studies indicated that -arrestin-2 specifically colocalized and associated with ERK1/2 to prevent ERK1/2-dependent cPLA(2) activation following ischemic injury, and -arrestin-2 deficiency blocked the negative regulation of phospho-ERK1/2, revived the association of phospho-ERK1/2 with phospho-cPLA(2), and subsequently increased the prostaglandin E2 and thromboxane A2 production remarkably. Our findings may provide novel insights that -arrestin-2 is responsible for ischemic brain improvement in TLR4(-/-) mice via negative regulation of eicosanoid production.Xiang, Y., Wei, X., Du, P., Zhao, H., Liu, A., Chen, Y. -Arrestin-2-ERK1/2 cPLA(2) axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain.

Β-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (Tlr4)-Triggered Inflammatory Signaling Via Targeting P38 MAPK and Interleukin 10.

Shp-2 Phosphatase Negatively Regulates The Trif Adaptor Protein-Dependent Type I Interferon And Proinflammatory Cytokine Production

β-Arrestin 2 regulates toll-like receptor 4-mediated apoptotic signalling through glycogen synthase kinase-3β: β-arrestin 2 regulates TLR4-mediated apoptosis

β-arrestin 2 attenuates lipopolysaccharide-induced liver injury via inhibition of TLR4/NF-κB signaling pathway-mediated inflammation in mice.

β-Arrestin-2-ERK1/2 cPLA 2 α axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain.

β-arrestin 2 regulates Toll-like receptor 4-mediated apoptotic signalling through glycogen synthase kinase-3β.

MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase

β-Arrestins 1 and 2 are critical regulators of inflammation

β-arrestin2: an emerging player and potential therapeutic target in inflammatory immune diseases

Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation.

The role and mechanism of β-arrestin2 in signal transduction

β‐arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4

Β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein.

The P38‐interacting Protein P38ip Suppresses TCR and LPS Signaling by Targeting TAK1

Β-Arrestin Signaling and Regulation of Transcription

TLR10 Is a Negative Regulator of Both MyD88-Dependent and -Independent TLR Signaling

Β-Arrestin 2 Inhibits TNFα Induced IKKα/β Activation by Interacting with RIP1

Β-Arrestin1 is Critical for the Full Activation of NLRP3 and NLRC4 Inflammasomes

Modulation of Toll–interleukin 1 receptor mediated signaling

Β-Arrestin2 is Critically Involved in CXCR4-mediated Chemotaxis, and This is Mediated by Its Enhancement of P38 MAPK Activation

Beta-Arrestin 2 Quenches Tlr Signaling To Facilitate The Immune Evasion Of Epec